Concepedia

C.J. Bol

CB

Statistics

Publications

7

Citations

666

H-Index

7

Active since

2000

Affiliations

Janssen (Belgium)(Current)

Rotterdam University of Applied Sciences

C.J. Bol is an author at Janssen (Belgium) specializing in medicine, pharmacotherapy, and drug resistance.

Top concepts

Publications per year

2000–2009

7

Publications

7

Phase I and Pharmacokinetic Study of Farnesyl Protein Transferase Inhibitor R115777 in Advanced Cancer

J. Zujewski, Ivan D. Horak, C.J. Bol et al. · Journal of Clinical Oncology · 2000 · 265 citations

Phase I Clinical and Pharmacologic Study of Chronic Oral Administration of the Farnesyl Protein Transferase Inhibitor R115777 in Advanced Cancer

Mirjam Crul, G.J.M. de Klerk, M. Swart et al. · Journal of Clinical Oncology · 2002 · 130 citations

The orally administered P-glycoprotein inhibitor R101933 does not alter the plasma pharmacokinetics of docetaxel.

Lia van Zuylen, Alex Sparreboom, Ate van der Gaast et al. · PubMed · 2000 · 100 citations

, , +11

Phase I and pharmacokinetic study of the orally administered farnesyl transferase inhibitor R115777 in patients with advanced solid tumors

Cornelis J. A. Punt, L. van Maanen, C.J. Bol et al. · Anti-Cancer Drugs · 2001 · 72 citations

Disposition of docetaxel in the presence of P-glycoprotein inhibition by intravenous administration of R101933

Lia van Zuylen, Alex Sparreboom, Ate van der Gaast et al. · European Journal of Cancer · 2002 · 65 citations

, , +6

1–5 of 7